Sabra Healthcare REIT (NASDAQ:SBRA) Releases Earnings Results, Misses Expectations By $0.05 EPS

Posted by Brenda Bartman on Nov 2nd, 2026

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) announced its quarterly earnings data on Monday. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.05), FiscalAI reports. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. During the same quarter in the prior year, the company earned $0.38 earnings per share. The company’s quarterly revenue was up 31.4% on a year-over-year basis.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA opened at $19.72 on Tuesday. The firm’s 50 day simple moving average is $19.86 and its 200 day simple moving average is $19.96. Sabra Healthcare REIT has a fifty-two week low of $17.53 and a fifty-two week high of $22.77. The company has a market capitalization of $5.04 billion, a price-to-earnings ratio of 75.85, a P/E/G ratio of 1.73 and a beta of 0.63. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07.

Insider Transactions at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on SBRA. Raymond James Financial raised shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Huntington started coverage on Sabra Healthcare REIT in a research report on Thursday, September 10th. They issued an “outperform” rating and a $23.00 price target on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Mizuho set a $21.00 price objective on Sabra Healthcare REIT in a research note on Monday, August 31st. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average price target of $21.50.

Read Our Latest Report on SBRA

Sabra Healthcare REIT News Summary

Here are the key news stories impacting Sabra Healthcare REIT this week:

Positive Sentiment: Sabra reported third-quarter earnings of $0.41 per diluted share, exceeding the consensus estimate of $0.16 and rising from $0.38 in the year-ago quarter. Revenue increased 31.4% year over year to $249.6 million, ahead of the $236.6 million analyst estimate. Earnings Flash
Positive Sentiment: Key REIT performance measures were solid: third-quarter FFO was $0.40 per share, normalized FFO was $0.39, AFFO was $0.45 and normalized AFFO was $0.41. FFO surpassed the $0.40 consensus estimate and increased from $0.38 a year earlier. Sabra Tops Q3 FFO and Revenue Estimates
Positive Sentiment: Management raised 2026 EPS guidance to $1.54-$1.55, above the $1.52 consensus forecast. The higher outlook may support investor confidence in operating performance and cash-generation prospects. Sabra Reports Third Quarter 2026 Results and Updates Guidance
Positive Sentiment: Sabra also declared its quarterly dividend, reinforcing the stock’s income appeal for REIT investors. Sabra Reports Results and Declares Dividend
Neutral Sentiment: Despite the earnings beat and improved guidance, the shares were little changed, suggesting investors may have largely anticipated the strong results or remain focused on REIT-specific factors such as interest rates, leverage and healthcare-property risks.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.